With an income increase of 1.43% in the fourth quarter 2025, year on year to cumulative value of $102,434 million, and with 69,505 employees, Novo Nordisk A's income per employee grew on trailing twelve month basis to $ 1,473,764, this marks a new company high for all of 69,505 employees.
The Healthcare sector has seen Novo Nordisk A achieved the highest income per employee. While income per employee remained unchanged compared to the previous quarter at no. .

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVO Net Income per Employee	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Net Income Change	1.43 %	-	-	-	-
Net Income per Employee (TTM) $	1,473,764	1,452,960	1,452,960	1,452,960	1,452,960
NVO's Total Ranking	#	#	#	#	#
Seq. Net Income Change	-	-	-	-	-

NVO Company Profile >> Back to NVO Efficiency Comparisons >> Compare NVO Net Income per Employee to its Competitors

NVO Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Net Income per Employee Statistics
High	Average	Low
$ 1,473,764	$ 1,473,764	$ 1,473,764
(Dec 31 2025)

Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector	Income per Employee	Income 12 month ending Dec 31 2025	Number of Employees Dec 31 2025
Atara Biotherapeutics Inc	2,334,857.14	$ 32.688 Million	14
Aurinia Pharmaceuticals Inc	2,243,765.63	$ 287.202 Million	128
Rigel Pharmaceuticals Inc	2,109,333.33	$ 367.024 Million	174
Elutia Inc	2,053,076.92	$ 53.380 Million	26
Inmode Ltd	1,914,918.37	$ 93.831 Million	49
Innoviva Inc	1,705,440.25	$ 271.165 Million	159
Compugen Ltd	1,683,000.00	$ 35.343 Million	21
Exelixis Inc	1,502,856.15	$ 1,723.776 Million	1,147
Novo Nordisk A	1,473,764.48	$ 102,434.000 Million	69,505
Zevra Therapeutics Inc	1,364,409.84	$ 83.229 Million	61
Xoma Royalty Corporation	1,322,571.43	$ 18.516 Million	14
Glucotrack Inc	1,292,533.33	$ 19.388 Million	15
Q32 Bio Inc	1,242,541.67	$ 29.821 Million	24
Pulmatrix Inc	1,205,500.00	$ 2.411 Million	2
Capsovision Inc	1,195,050.51	$ 118.310 Million	99
Catalyst Pharmaceuticals Inc	1,177,615.38	$ 214.326 Million	182
Theravance Biopharma inc	1,176,611.11	$ 105.895 Million	90
Coherus Oncology inc	1,143,020.41	$ 168.024 Million	147
Argenx Se	1,125,466.03	$ 1,292.035 Million	1,148
Tg Therapeutics Inc	1,120,749.37	$ 447.179 Million	399
Rafael Holdings Inc	1,119,000.00	$ 25.737 Million	23
Keros Therapeutics Inc	1,115,564.10	$ 87.014 Million	78
Black Diamond Therapeutics Inc	1,065,095.24	$ 22.367 Million	21
Galapagos Nv	984,630.36	$ 359.390 Million	365
United Therapeutics Corporation	953,357.14	$ 1,334.700 Million	1,400
Silexion Therapeutics Corp	850,857.14	$ 11.912 Million	14
Prestige Consumer Healthcare Inc	795,059.65	$ 453.184 Million	570
Petros Pharmaceuticals inc	787,672.33	$ 2.363 Million	3
Heartflow Inc	773,161.33	$ 651.775 Million	843
Chemomab Therapeutics Ltd	749,583.33	$ 8.995 Million	12

Date modified: 2026-07-07T12:35:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.